JPS6016232B2 - Method for producing enzyme for reproducing adenosine triphosphate - Google Patents
Method for producing enzyme for reproducing adenosine triphosphateInfo
- Publication number
- JPS6016232B2 JPS6016232B2 JP290080A JP290080A JPS6016232B2 JP S6016232 B2 JPS6016232 B2 JP S6016232B2 JP 290080 A JP290080 A JP 290080A JP 290080 A JP290080 A JP 290080A JP S6016232 B2 JPS6016232 B2 JP S6016232B2
- Authority
- JP
- Japan
- Prior art keywords
- acetate kinase
- adenosine triphosphate
- elution
- production method
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 title claims description 20
- 102000004190 Enzymes Human genes 0.000 title claims description 18
- 108090000790 Enzymes Proteins 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 title claims description 8
- 108010092060 Acetate kinase Proteins 0.000 claims description 38
- 239000000872 buffer Substances 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- 238000010828 elution Methods 0.000 claims description 11
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 8
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 239000001103 potassium chloride Substances 0.000 claims description 5
- 235000011164 potassium chloride Nutrition 0.000 claims description 5
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 229920003176 water-insoluble polymer Polymers 0.000 claims description 3
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 claims description 2
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- -1 their high reaction Substances 0.000 description 28
- 229940088598 enzyme Drugs 0.000 description 16
- 239000007853 buffer solution Substances 0.000 description 11
- 239000000284 extract Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 4
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000000287 crude extract Substances 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 102000001253 Protein Kinase Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- 230000002407 ATP formation Effects 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000005377 adsorption chromatography Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000004255 ion exchange chromatography Methods 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011403 purification operation Methods 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229960002385 streptomycin sulfate Drugs 0.000 description 2
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 description 1
- ZTNJGMFHJYGMDR-UHFFFAOYSA-N 1,2-diisocyanatoethane Chemical compound O=C=NCCN=C=O ZTNJGMFHJYGMDR-UHFFFAOYSA-N 0.000 description 1
- YCGKJPVUGMBDDS-UHFFFAOYSA-N 3-(6-azabicyclo[3.1.1]hepta-1(7),2,4-triene-6-carbonyl)benzamide Chemical compound NC(=O)C1=CC=CC(C(=O)N2C=3C=C2C=CC=3)=C1 YCGKJPVUGMBDDS-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- WRDNCFQZLUCIRH-UHFFFAOYSA-N 4-(7-azabicyclo[2.2.1]hepta-1,3,5-triene-7-carbonyl)benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C(=O)N1C2=CC=C1C=C2 WRDNCFQZLUCIRH-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000117129 Atylus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920000571 Nylon 11 Polymers 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 229920001007 Nylon 4 Polymers 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004693 Polybenzimidazole Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000282330 Procyon lotor Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BIGPRXCJEDHCLP-UHFFFAOYSA-N ammonium bisulfate Chemical compound [NH4+].OS([O-])(=O)=O BIGPRXCJEDHCLP-UHFFFAOYSA-N 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000012461 cellulose resin Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 125000003709 fluoroalkyl group Chemical group 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- OIAUFEASXQPCFE-UHFFFAOYSA-N formaldehyde;1,3-xylene Chemical compound O=C.CC1=CC=CC(C)=C1 OIAUFEASXQPCFE-UHFFFAOYSA-N 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000779 poly(divinylbenzene) Polymers 0.000 description 1
- 229920000141 poly(maleic anhydride) Polymers 0.000 description 1
- 229920003214 poly(methacrylonitrile) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 108010054442 polyalanine Proteins 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002480 polybenzimidazole Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920001228 polyisocyanate Polymers 0.000 description 1
- 239000005056 polyisocyanate Substances 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108010039177 polyphenylalanine Proteins 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229950008679 protamine sulfate Drugs 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 229920005612 synthetic inorganic polymer Polymers 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
【発明の詳細な説明】 本発明は、アデノシントリリン酸(以下ATPという。[Detailed description of the invention] The present invention relates to adenosine triphosphate (hereinafter referred to as ATP).
)再生産用酵素の製造法に関するものである。近時、酵
素の触媒としてすぐれた性質、すなわち反応、基質、光
学的な特異性が高いことや反応条件が温和である点が注
目され、化学工業、食品、医療その他多くの分野への利
用が検討され、実施されている。) This relates to a method for producing enzymes for reproduction. Recently, the excellent properties of enzymes as catalysts, such as their high reaction, substrate and optical specificity, and mild reaction conditions, have attracted attention, and their use in the chemical industry, food, medicine, and many other fields has attracted attention. It is being considered and implemented.
しかし、これらは現在のところ加水分解酵素の利用には
ほとんど限られている。しかるに、生体内においては、
主にATPをエネルギー源として利用して、多くの合成
酵素により生合成が行なわれている。この際、エネルギ
ー源として用いられたATPは、アデノシンジリン酸(
以下ADPという。)に変換されることになる。そこで
、従来の加水分解酵素の利用から脱却し、酵素の工業的
利用を広げるため、上記生体内で行なわれていると同様
な生合成を生体外において目ざそうとする全く新しい生
産システム、すなわち一般に、バイオリアクターと呼ば
れているシステムを創造することが試みられて来ている
。そのようなバイオリアクターを完成、実施するために
は、エネルギー源として多量のATPが必要であり、か
つ使用したATPをADPより再生産することが必要で
ある。このような目的に沿って、ADPからATPを再
生産する方法としては、次式の反応を触媒するホスホト
ランスフェラーゼと総称される酵素の使用が考えられる
。(R〜■;高エネルギーリン酸化合物、RH:R〜■
の加水分解物を表わす。However, these are currently mostly limited in their use as hydrolytic enzymes. However, in vivo,
Biosynthesis is carried out by many synthetic enzymes, mainly using ATP as an energy source. At this time, ATP used as an energy source was adenosine diphosphate (
Hereinafter referred to as ADP. ) will be converted to Therefore, in order to break away from the conventional use of hydrolytic enzymes and expand the industrial use of enzymes, we developed a completely new production system that aims to achieve biosynthesis in vitro similar to that carried out in vivo. Attempts have been made to create systems commonly referred to as bioreactors. In order to complete and implement such a bioreactor, a large amount of ATP is required as an energy source, and it is necessary to regenerate the used ATP from ADP. In line with this purpose, as a method for regenerating ATP from ADP, it is possible to use enzymes collectively called phosphotransferases that catalyze the reaction of the following formula. (R~■; High energy phosphoric acid compound, RH:R~■
represents a hydrolyzate of
)数あるホスホトランスフェラーゼのうちでも、■平衡
反応が、十分ATP合成側に片よっていること、■リン
酸化合物R〜■が工業的に容易に、かつ安価に得られる
こと、■酵素標品が容易に十分に純粋になるか、あるい
は不純な場合にも、混在するATP分解酵素や阻害物質
を含まないことが重要である。) Among the many phosphotransferases, ■ the equilibrium reaction is sufficiently biased toward ATP synthesis, ■ the phosphoric acid compounds R ~ ■ can be obtained industrially easily and inexpensively, and ■ the enzyme preparations are It is important that it is easily made sufficiently pure, or even if it is impure, that it does not contain contaminating ATP-degrading enzymes or inhibitors.
このような条件をかなり満足する酵素としては、酢酸キ
ナーゼ(酵素番号2.7.2.1)がある。酢酸キナー
ゼは、その平衡反応がATP合成側に約123音かたよ
っており、さらに、リン酸化合物R〜■であるアセチル
リン酸は工業的に容易に安価に得ることができ、上記条
件の■および■については十分に満している。しかしな
がら、従来知られている酢酸キナーゼはエシエリキア・
コリあるいはバチルス・ステアロサーモフィルス等から
得られているものであるが、この酢酸キナーゼを採取す
る方法は、酢酸キナーゼが菌体内酵素であるため菌体を
破壊して得た上燈から抽出する方法が一般であり、その
ため上澄には菌体由来の種々が混在し目的とする酵素の
分離精製は非常に困難である。An example of an enzyme that satisfies these conditions is acetate kinase (enzyme number 2.7.2.1). In the case of acetate kinase, the equilibrium reaction is shifted approximately 123 times toward the ATP synthesis side.Furthermore, acetyl phosphate, which is a phosphoric acid compound R~■, can be easily obtained industrially at low cost, and under the above conditions (■ and ③ is fully satisfied. However, the previously known acetate kinase is
Acetate kinase is obtained from bacteria such as Coli or Bacillus stearothermophilus, but since acetate kinase is an intracellular enzyme, it is extracted from the supernatant obtained by destroying the bacterial cells. This method is common, and as a result, the supernatant contains various substances derived from the bacterial cells, making it extremely difficult to separate and purify the desired enzyme.
たとえば、ェシェリキア・コリから酢酸キナーゼを採取
する場合には、ジヤーナル・オブ・バイオロジカル・ケ
ミストリー、211巻、73汀頁、195仏王に記載さ
れているように、粗分画抽出液を得たのち、さらにイオ
ン交換クロマトグラフィー、吸着クロマトグラフィー、
ゲルクロマトグラフィ一、等露点電気泳動法のはん雑な
精製を行なっても通常は約30%の純度までしか精製す
ることができなかった。特に等亀点電気泳敷法はスケー
ルアップが困難なため、酢酸キナーゼを大量に精製して
製造するには大きな障害であった。また、バチルス・ス
テアロサ−モフィルスから酢酸キナーゼを採取する場合
には、持関昭52一25088号やジャーナル・オブ・
バイオケミストリー、鶴巻、198頁、1978年に記
載されているように、菌体破壊後、ストレプトマイシン
による除核酸を行ない、得られた上燈を硫酸アンモニウ
ム塩折することにより粗酵素沈澱を得た後、DEAEセ
ル。ースカラムクロマトグラフィー、ヒドロキシア/ぐ
タイトカラムクロマトグラフイー、ウルトロゲルカラム
クロマトグラフイー、DEAEセフアデツクスカラムク
ロマトグラフイーなどをすべて行なう煩雑な工程を経て
精製が行なわれており、酢酸キナーゼの単位酵素あたり
の製造費が高く、バイオリアクターの工業的な展開に著
しい支障となっている。そこで、本発明者らは、これら
の観点から酢酸キナーゼを効率よく得ることは是非とも
必要なことであることから、簡単な精製操作で高純度の
酢酸キナーゼを効率よく得ることを目的として鋭意研究
した結果、特定の不水溶性の担体を用いて精製すると、
上記の目的がすべて達成されることを見し、出し、本発
明に到達した。For example, when collecting acetate kinase from Escherichia coli, a crude fractionated extract was obtained as described in Journal of Biological Chemistry, Volume 211, Page 73, page 195. Later, ion exchange chromatography, adsorption chromatography,
Even with complicated purification methods such as gel chromatography and dew point electrophoresis, it was usually possible to purify the product to a purity of only about 30%. In particular, the isokame spot electrophoresis method is difficult to scale up, which has been a major obstacle to purifying and producing acetate kinase in large quantities. In addition, when collecting acetate kinase from Bacillus stearothermophilus, please refer to Mochiseki No. 52-25088 and Journal of
As described in Biochemistry, Tsurumaki, p. 198, 1978, after the bacterial cells were disrupted, nucleic acid was removed with streptomycin, and the resulting supernatant was salted out with ammonium sulfate to obtain a crude enzyme precipitate. DEAE cell. Purification is carried out through a complicated process including acetic acid kinase column chromatography, hydroxyl acetate kinase column chromatography, Ultrogel column chromatography, and DEAE Sephadex column chromatography. The production cost per unit enzyme is high, which is a significant hindrance to the industrial development of bioreactors. Therefore, since it is absolutely necessary to efficiently obtain acetate kinase from these points of view, the present inventors have conducted intensive research with the aim of efficiently obtaining highly pure acetate kinase through simple purification operations. As a result, when purified using a specific water-insoluble carrier,
It has been found and devised that all of the above objectives are achieved, and the present invention has been arrived at.
すなわち、本発明は、酢酸キナーゼを産出する微生物を
培養し、得られた培養物を一般式(1)(ただしR,,
R2は日原子またはS03Na基から選ばれ、互に相異
なるもの、R3は水不溶性の高分子を表わす。That is, the present invention involves culturing a microorganism that produces acetate kinase, and culturing the resulting culture with the general formula (1) (where R, ,
R2 is selected from an atom or a S03Na group and is different from each other, and R3 represents a water-insoluble polymer.
)で示される水不溶性の担体で処理して酢酸キナ−ゼを
該担体に吸着させ、次いで吸着させた酢酸キナーゼを溶
出させることを特徴とするアデノシントリリン酸再生産
用酵素の製造法である。) A method for producing an enzyme for regenerating adenosine triphosphate is characterized in that acetate kinase is adsorbed onto the carrier by treatment with a water-insoluble carrier, and then the adsorbed acetate kinase is eluted.
本発明に用いられる酢酸キナーゼを産出する微生物とし
ては、酢酸キナーゼ生産性を持つ微生物であれば、いか
なるものでも使用できる。As the acetate kinase-producing microorganism used in the present invention, any microorganism can be used as long as it has acetate kinase productivity.
好ましい微生物としては、たとえば、バチルス・ステア
ロ サ ー モ フ イ ル ス ( Bacmuss
にarothrmophil船)やエシエリキア・コリ
(Escherjchiacoli)があげられる。特
に耐熱性酢酸キナーゼを産出するバチルス・ステアロサ
ーモフィルスが好ましい。これらの微生物を培養するに
は、たとえば、特開昭52一25088号公報に記載さ
れているように、グルコース、サツカ。ースまたはリン
ゴ酸などの炭素源および/またはべプトン、肉エキス、
アミノ酸などの窒素源、さらに必要ならば無機塩類およ
び/またはビタミンなどを含む通常の微生物の培養に使
用される培地条件下で培養すればよい。本発明における
一般式(1)で示される水不落性の担体とは、ブルー色
素と水不落性の高分子とを反応させた水に不溶性の化合
物をいい、この水不溶性の高分子としては、たとえばセ
ルロース、デキストラン、アガロース、デンプンなどの
多糖類の誘導体、ポリ酢酸セルロース、ポリビニルアル
コールの誘導体、ポリスチレン、ポリプロピレン、ポリ
エチレン、ポリビニルクロライド、ポリ(メチルメタク
リル酸)ヱステル、ポリブデン、ポリベンテン、ポリビ
ニルデンクロライド、ポリアクリロニトリル、ポリメタ
クリル酸、ポリアクリル酸、ポリアミノスチレン、ポリ
ブタジェン、ポリィソプレソ、ポリマレィン酸モノェス
テル、架橋ポリアクリルアミド、ポリメタクリルアミド
、ポリビニルアミン、ポリ(ジアルキルアミノェチルメ
タクリル酸ェステル)、ポリ(ジアルキルアミノメチル
スチレン)、ポリ(ビニルピリジン)、ポリ(ビニルピ
ロリドン)、ポリアクリル酸無水物、ポリメタクリル酸
無水物、ポリマレィン酸無水物、ポリメタクリロニトリ
ル、ボリ(トリフルオロエチレン)、ポリ(テトラフル
オロエチレン)、ポリ(ジビニルベンゼン)、ポリ(Q
ーメチルスチレン)、ポリ(Nービニルアミン)、ポリ
(テトラメチレングリコールジビニルエーアル)、ポリ
ビニルスルホン、ポリビニルスルホキシド、ポリアクロ
レイン、ポリメチルピニルケトンなどの不飽和炭素を含
む単量体からなる重合体、ポリフエニレンオキシド、ポ
リメチレンオキシド、ポリエチレンオキシド、ポリテト
ラメチレンオキシドなどのポリェーテル類、ポリアラニ
ン、ポリフェニルアラニンなどのポリベプチド類、ナイ
ロン一3、ナイロン一4、ナイ。Preferred microorganisms include, for example, Bacillus stearothermophilus.
Examples include arthromophilic vessels) and Escherjchiacoli. In particular, Bacillus stearothermophilus, which produces thermostable acetate kinase, is preferred. In order to culture these microorganisms, for example, as described in Japanese Patent Application Laid-Open No. 52-25088, glucose, sugar, etc. are used. carbon sources such as carbonaceous acid or malic acid and/or veptone, meat extract,
The culture may be carried out under medium conditions commonly used for culturing microorganisms, which contain a nitrogen source such as amino acids, and if necessary, inorganic salts and/or vitamins. In the present invention, the water-impregnable carrier represented by the general formula (1) refers to a water-insoluble compound obtained by reacting a blue dye with a water-impregnable polymer, and as this water-insoluble polymer, For example, cellulose, dextran, agarose, derivatives of polysaccharides such as starch, cellulose polyacetate, derivatives of polyvinyl alcohol, polystyrene, polypropylene, polyethylene, polyvinyl chloride, poly(methyl methacrylate) ester, polybutene, polybentene, polyvinyldene chloride , polyacrylonitrile, polymethacrylic acid, polyacrylic acid, polyaminostyrene, polybutadiene, polyisopresso, polymaleic acid monoester, crosslinked polyacrylamide, polymethacrylamide, polyvinylamine, poly(dialkylaminoethyl methacrylate), poly(dialkylaminomethyl) styrene), poly(vinylpyridine), poly(vinylpyrrolidone), polyacrylic anhydride, polymethacrylic anhydride, polymaleic anhydride, polymethacrylonitrile, poly(trifluoroethylene), poly(tetrafluoroethylene) , poly(divinylbenzene), poly(Q
-methylstyrene), poly(N-vinylamine), poly(tetramethylene glycol divinyl ether), polyvinyl sulfone, polyvinyl sulfoxide, polyacrolein, polymethylpinyl ketone, and other polymers made of monomers containing unsaturated carbon, polyphenylene Polyethers such as nylene oxide, polymethylene oxide, polyethylene oxide, and polytetramethylene oxide, polypeptides such as polyalanine and polyphenylalanine, nylon-13, nylon-4, and nylon.
ンー5、ナイロン一6、ナイロン−7、ナイロン−11
、ナイロン−12、ナイロン一6,6、ナイロン一6,
1い ポリ(mーフエニレンーイソフタラミド、ポリ(
p−フエニレンーテレフタラミド)などのポリアミド、
テレフタル酸、ィソフタル酸、アジピン酸、マレィン酸
、フマル酸、トリメリット酸などのポリカルボン酸と、
エチレングリコール、プ。ピレングリコール、ブチレン
グリコール、ベンタエリスリトール、ビスフエノールA
などのポリオールとから誘導されるポリエステル類、グ
リコール類、乳酸、ヒドロキシピリバリン酸などから誘
導されるポリエステル、ジメチルポリシロキサン、メチ
ルフエニルポリシロキサン、メチルビニルポリシロキサ
ン、シアノアルキルメチルポリシロキサン、フルオロア
ルキルメチルポリシロキサンなどのシリコンゴム、トル
エンジイソシアナート、キシレンジイソシアナート、フ
ヱニレンジイソシアナート、エチレンジイソシアナート
、ジフエニルメタンジイソシアナート、トルエントリイ
ソシアナートなどのポリイソシアナートと、ポリエチレ
ングリコール、ポリプロピレングリコール、両末端にO
H基を有するポリエステルなどのポリオールとから誘導
されるポリウレタン類、フェノールーホルムアルデヒド
樹脂、キシレンーホルムアルデヒド樹脂、尿素ーホルム
アルデヒド樹脂、メラミンーホルムアルデヒド樹脂など
のホルムアルデヒド樹脂、ポリィミド、ポリベンツィミ
ダゾール、ポリチアゾールなどの4員環を含むポリマー
、ポリカーボナート、ポリスルホンなどの合成ポリマー
およびガラス、アスベスト、クレイ、マィカ、ヒドロキ
シルアパタィト活性炭、シリカゲル、アルミナなどの無
機物の誘導体およびポリフオスフアゼンのような合成無
機ポリマーなどがあげられる。この一般式(1)で示さ
れる水不落・性の迫体の具体例として、たとえば、市販
のブルーセフア。N-5, Nylon-6, Nylon-7, Nylon-11
, nylon-12, nylon-16,6, nylon-16,
1 Poly(m-phenylene-isophthalamide, Poly(
polyamides such as p-phenylene-terephthalamide),
Polycarboxylic acids such as terephthalic acid, isophthalic acid, adipic acid, maleic acid, fumaric acid, trimellitic acid,
Ethylene glycol, p. Pyrene glycol, butylene glycol, bentaerythritol, bisphenol A
Polyesters derived from polyols such as glycols, lactic acid, polyesters derived from hydroxypyribalic acid, dimethylpolysiloxane, methylphenylpolysiloxane, methylvinylpolysiloxane, cyanoalkylmethylpolysiloxane, fluoroalkyl Silicone rubber such as methylpolysiloxane, polyisocyanate such as toluene diisocyanate, xylene diisocyanate, phenylene diisocyanate, ethylene diisocyanate, diphenylmethane diisocyanate, and toluene diisocyanate, and polyethylene glycol. , polypropylene glycol, O at both ends
Polyurethanes derived from polyols such as polyesters having H groups, formaldehyde resins such as phenol-formaldehyde resins, xylene-formaldehyde resins, urea-formaldehyde resins, and melamine-formaldehyde resins, polyimides, polybenzimidazole, polythiazole, etc. Synthetic polymers such as polymers containing four-membered rings, polycarbonate, polysulfone, and inorganic derivatives such as glass, asbestos, clay, mica, hydroxylapatite activated carbon, silica gel, alumina, and synthetic inorganic polymers such as polyphosphazene etc. A specific example of the water-proof and sexual essence represented by the general formula (1) is, for example, commercially available Blue Sefa.
ーズやマトレツクス・フルーAがあげられる。本発明に
おいて、上記の担体に酢酸キナーゼを吸着させることが
必要である。そのためには、培養物から菌体を集菌し、
その集菌した菌体をたとえば、フレンチプレス、マント
ンゴーリン、超音波、凍結融解、ダィノミル等で破砕し
て粗抽出液を得ればよいし、硫酸ストレプトマイシンま
たは硫酸プロタミン等で除核酸処理した除核酸抽出液、
硫酸アンモニア、アセトン等で分画した粗分画抽出液さ
らにはイオン交換クロマトグラフィーや吸着クロマトグ
ラフィー等により前処理した前分画抽出液であってもよ
い。この抽出液と上記の担体とを単に混合するかあるい
はカラムに充填した上記の担体に通液して酢酸キナーゼ
を吸着させることができる。次に、本発明においては吸
着させた酢酸キナ−ゼを溶出させることが必要である。Examples of these include ``Full-A'' and Matrex Flue A. In the present invention, it is necessary to adsorb acetate kinase onto the above-mentioned carrier. To do this, collect bacteria from the culture,
The collected bacterial cells may be crushed using a French press, Manton Gaulin, ultrasound, freeze-thaw, Dynomyl, etc. to obtain a crude extract, or the nucleic acid removed by treatment with streptomycin sulfate or protamine sulfate, etc. extract,
A crudely fractionated extract obtained by fractionation using ammonia sulfate, acetone, etc. or a pre-fractionated extract obtained by pretreatment by ion exchange chromatography, adsorption chromatography, etc. may be used. Acetate kinase can be adsorbed by simply mixing this extract and the above-mentioned carrier, or by passing the solution through the above-mentioned carrier packed in a column. Next, in the present invention, it is necessary to elute the adsorbed acetate kinase.
そのためには、まず、酢酸キナーゼの吸着した担体を緩
衝液で洗浄し、狸体に吸着しない抽出液中の爽雑タンパ
クを除くことが望ましい。この際、吸着した酢酸キナー
ゼが溶出しない条件を選ぶことが望ましい。そのために
は、緩衝液のイオン強度は0.001からo.15禾満
の範囲、好ましくは0.01から0.10さらに0.0
5から0.10の範囲が最適である。次いで、このよう
にして洗浄した後、たとえば以下に述べる溶出液を用い
て酢酸キナーゼを溶出すればよい。溶出液としては、酢
酸キナーゼの活性が損なわれず、かつ担体から酢酸キナ
ーゼが溶出しうるものであればいかなるものでもよいが
、その中でも酢酸キナーゼが特異的に溶出する、10の
MのATPを含有する緩衝液、10のMのATPと10
0のMの塩化カリウムとを含有する緩衝液、lowMの
ATPと100mMの塩化ナトリウムとを含有する緩衝
液が好ましく、さらにバチルス・ステアロサーモフイル
スを用いる場合には、2のMのATPと1仇Mのフルク
トースー1.6−ジリン酸とを含有する緩衝液が好まし
い。この緩衝液のpHは5〜lu好ましくは6〜9、特
に7〜9が好ましい。また、溶出させる方法としては緩
衝液を一度に加える、いわゆる回分式溶出法でもよいし
、あるいは緩衝液の濃度を連続的に上昇させて溶出させ
る、いわゆる濃度勾配溶出法でもよい。本発明によれば
、等軍点電気泳動法を用いずに、さらに従釆のクロマト
グラフィーのうち、いくつかを省略して高純度の酢酸キ
ナーゼを効率よく得ることができ、精製に要する時間を
大中に短縮することができる。To this end, it is desirable to first wash the carrier on which acetate kinase has been adsorbed with a buffer solution to remove extraneous proteins in the extract that do not adsorb to the raccoon body. At this time, it is desirable to select conditions that do not cause the adsorbed acetate kinase to elute. For this purpose, the ionic strength of the buffer solution must be between 0.001 and o. In the range of 15 degrees, preferably from 0.01 to 0.10 and even 0.0
A range of 5 to 0.10 is optimal. After washing in this manner, acetate kinase may then be eluted using, for example, the eluent described below. Any eluent may be used as long as the activity of acetate kinase is not impaired and acetate kinase can be eluted from the carrier, but among these, the eluent contains 10 M ATP, which specifically elutes acetate kinase. buffer, 10 M ATP and 10
Buffers containing 0 M potassium chloride, low M ATP and 100 mM sodium chloride are preferred, and when Bacillus stearothermophilus is used, 2 M ATP and 1 A buffer solution containing fructose-1,6-diphosphate is preferred. The pH of this buffer is preferably 5 to lu, preferably 6 to 9, particularly preferably 7 to 9. Further, the elution method may be a so-called batch elution method in which a buffer solution is added at once, or a so-called concentration gradient elution method in which elution is performed by continuously increasing the concentration of a buffer solution. According to the present invention, highly pure acetate kinase can be obtained efficiently without using isomerical point electrophoresis and by omitting some of the related chromatography, and the time required for purification is reduced. It can be shortened to large.
次に本発明を実施例により具体的に説明する。Next, the present invention will be specifically explained using examples.
実施例 1バチルス・ステアロサーモフイルNCA15
03の湿菌体500夕を2倍量の100のMトリスー塩
酸緩衝液(pH8.0)に懸濁し、ダィノミルを用いて
細胞を十分に破壊した後、遠心分離により細胞片を除去
し、酢酸キナーゼを含む粗抽出液を得た。Example 1 Bacillus stearothermophile NCA15
500 wet bacterial cells of No. 03 were suspended in twice the amount of 100 M Tris-HCl buffer (pH 8.0), the cells were sufficiently disrupted using Dynomil, cell debris was removed by centrifugation, and acetic acid was added. A crude extract containing the kinase was obtained.
この粗抽出液を、あらかじめ5mM塩化マグネシウムと
100mM塩化カルウムを含む50mMトリスー塩酸緩
衝液(pH80)で平衡化したブルーセフアロース(フ
ァルマシア社製)をつめたカラムに通液した。粗抽出液
の通液後、上記緩衝液で未吸着の交雑タンパクなどを洗
浄した。ついで上記緩衝液と上記緩衝液に2WHATP
と2のMフルクトースー1.6ージリン酸を含んだ緩衝
液で直線勾配の溶出を行なうと、ATP濃度で約0.5
仇Mの近くに目的の酢酸キナーゼが溶出した。この画分
を補集し、30mMリン酸緩衝液(pH7.0)であら
かじめ平衡化したDEAE−セフアデックスカラムに通
じ、30mMリン酸緩衝液(pH7.0)と、これに4
00のMの塩化カリウムを添加した溶液との直線濃度勾
配による溶出を行なった。塩化カリウム濃度約150m
Mの近くに目的の酢酸キナーゼが溶出した。このように
して得た酢酸キナーゼはアクリルアミドディスク電気泳
動で単一なバンドを与え、さらにウルトロゲルACA私
クロマトグラフィーにおいても、分子量約16方のとこ
ろに単一のピークを与え、ほぼ100%の純度を有して
いる。This crude extract was passed through a column filled with Blue Sepharose (manufactured by Pharmacia) that had been equilibrated with 50 mM Tris-HCl buffer (pH 80) containing 5 mM magnesium chloride and 100 mM potassium chloride. After passing the crude extract, unadsorbed hybrid proteins and the like were washed with the above buffer. Then add 2WHATP to the above buffer solution and the above buffer solution.
When linear gradient elution is performed with a buffer containing 2 M fructose-1.6-diphosphate, the ATP concentration is approximately 0.5
The target acetate kinase was eluted near the enemy M. The fractions were collected and passed through a DEAE-Sephadex column pre-equilibrated with 30mM phosphate buffer (pH 7.0) and 30mM phosphate buffer (pH 7.0).
Elution was carried out by a linear concentration gradient with a solution supplemented with 0.00 M potassium chloride. Potassium chloride concentration approximately 150m
The target acetate kinase was eluted near M. Acetate kinase obtained in this way gave a single band in acrylamide disc electrophoresis, and also gave a single peak at a molecular weight of about 16 in Ultrogel ACA I chromatography, indicating almost 100% purity. have.
また、収量は約30の9で、酵素Imp当り約1,50
山単位の力価を示している。このように従釆に比べ高収
率なものが得られ、精製のための操作は大中に軽減され
た。実施例 2
ェシェリキア・コリから得られた市販の粗酢酸キナーゼ
標品5,00山単位(純度はアクリルアミドディスク電
気泳動法により検定した結果、約30%であった)を2
0mMィミダーゾールー塩酸、5mM塩化マグネシウム
、2mMメルカプトェタノールよりなる緩衝液に対して
透析した。In addition, the yield is about 30:9, about 1,50 per enzyme Imp.
The titer per mountain is shown. In this way, higher yields were obtained than in the secondary method, and the number of purification operations was reduced. Example 2 5,00 units of a commercially available crude acetate kinase preparation obtained from Escherichia coli (purity was approximately 30% as determined by acrylamide disc electrophoresis) were
Dialysis was performed against a buffer consisting of 0mM imidazole-hydrochloric acid, 5mM magnesium chloride, and 2mM mercaptoethanol.
この溶液をあらかじめ上記緩衝液で平衡化したマトレッ
クス・フルーA(アミコン社製)をつめたカラムに通し
100mMの塩化ナトリウム、20mMイミダゾールー
塩酸、5のM塩化マグネシウム、2mM〆ルカプトェタ
ノールよりなる緩衝液で洗浄した。ついで、洗浄した緩
衝液で食塩濃度を最終的に500mMとなるように直線
濃度勾配で溶出を行なうと、食塩濃度約300mMの近
くに目的とする酢酸キナーゼが溶出した。このようにし
て得た酢酸キナーゼは、アクリルァミドディスク電気泳
動法により検定した結果、純度91%であり、回収され
た酢酸キナーゼは4800単位であった。This solution was passed through a column filled with Matrex Fluor A (manufactured by Amicon) that had been equilibrated with the above buffer solution and was composed of 100mM sodium chloride, 20mM imidazole-hydrochloric acid, 5M magnesium chloride, and 2mM captoethanol. Washed with buffer. Then, elution was carried out using a linear concentration gradient using the washed buffer solution so that the final salt concentration was 500 mM, and the target acetate kinase was eluted near a salt concentration of about 300 mM. The thus obtained acetate kinase was assayed by acrylamide disc electrophoresis and found to have a purity of 91%, and the amount of acetate kinase recovered was 4800 units.
実施例 3/ゞチルス・ステアロサーモフイルスATC
C7954の湿菌体lk9を2倍量の100mMリン酸
緩衝液(pH7.4)に懸濁し、フレンチプレスにて細
胞を破壊した後、遠心分離により不溶物を除去し、酢酸
キナーゼを含め粗抽出液を得た。Example 3/Atylus stearothermophilus ATC
C7954 wet cell lk9 was suspended in twice the volume of 100mM phosphate buffer (pH 7.4), the cells were disrupted using a French press, and insoluble matter was removed by centrifugation, and crude extraction including acetate kinase was performed. I got the liquid.
この抽出液600私当り10%硫酸ストレプトマイシン
溶液300双‘添加後、生じた次でんを遠D分離で除去
し、除核酸後抽出液を得た。これに硫酸アンモニウム分
割をほどこし、30%飽和(4℃)から45%飽和(4
℃)の間の分割部を得た。この分割部を20mMリン酸
緩衝液(pH7.0)にとかした。次にあらかじめ20
mMリン酸緩衝液(pH7.0)で平衡化したDEAE
−セルロース樹脂と上記の溶液とを混合したのち沈でん
を渡80した。この沈でんを150mM塩化ナトリウム
を含む上記緩衝液で洗浄した。めでんをさらに250m
M塩化ナトリウムを含む20mMリン酸緩衝液で洗浄し
、この櫨液を摘果した。この猿液を100mM塩化ナト
リウム、5のM塩化マグネシウムを含む50mMイミダ
ゾールー塩酸緩衝液に対して透析したのち、ブルーセフ
ァロースと30分間混合した。この混合液を猿過し、枕
でんを上記緩衝液で洗浄後、10のMのATPを含む上
記緩衝液で洗浄した。後者の洗浄液を補集すると、目的
とする酢酸キナーゼが、70,00の単位得られた。引
続き、ウルトロゲルACA34ク。After adding 300 μl of 10% streptomycin sulfate solution per 600 μl of this extract, the resulting particles were removed by centrifugal D separation to obtain a nucleic acid-free extract. This was subjected to ammonium sulfate separation, and from 30% saturation (4℃) to 45% saturation (4℃).
℃) were obtained. This divided portion was dissolved in 20 mM phosphate buffer (pH 7.0). Next, 20
DEAE equilibrated with mM phosphate buffer (pH 7.0)
- After mixing the cellulose resin and the above solution, a precipitate was passed for 80 minutes. This precipitate was washed with the above buffer containing 150mM sodium chloride. 250m further along Meden
The fruit was washed with 20mM phosphate buffer containing M sodium chloride, and the fruit was harvested. This monkey fluid was dialyzed against a 50 mM imidazole-hydrochloric acid buffer containing 100 mM sodium chloride and 5 M magnesium chloride, and then mixed with blue sepharose for 30 minutes. This mixture was filtered, and the makuraden was washed with the above buffer solution, and then with the above buffer solution containing 10 M ATP. Collecting the latter wash yielded 70,00 units of the desired acetate kinase. Next, Ultrogel ACA34.
Claims (1)
培養物を一般式I▲数式、化学式、表等があります▼ (ただしR_1,R_2はH原子またはSO_3Na基
から選ばれ、互に相異なるもの、R_3は水不溶性の高
分子を表わす。 )で示される水不溶性の担体で処理して酢酸キナーゼを
該担体に吸着させ、次いで吸着させた酢酸キナーゼを溶
出させることを特徴とすアデノシントリリン酸再生産用
酵素の製造法。 2 酢酸キナーゼを産出する微生物がバチルス・ステア
ロサーモフイラスである特許請求の範囲第1項記載の製
造法。 3 10mMのアデノシントリリン酸を含有する緩衝液
で溶出させる特許請求の範囲第1項記載の製造法。 4 10mMのアデノシントリリン酸と100mMの塩
化カリウムとを含有する緩衝液で溶出させる特許請求の
範囲第1項記載の製造法。 5 10mMのアデノシントリリン酸と100mMの塩
化ナトリウムとを含有する緩衝液で溶出させる特許請求
の範囲第1項記載の製造法。 6 2mMのアデノシントリリン酸と1mMのフルクト
ース−1.6−ジリン酸とを含有する緩衝液で溶出させ
る特許請求の範囲第1項または第2項記載の製造法。[Scope of Claims] 1. A microorganism that produces acetate kinase is cultivated, and the resulting culture is expressed by the general formula I▲There are mathematical formulas, chemical formulas, tables, etc.▼ (However, R_1 and R_2 are selected from H atoms or SO_3Na groups) , which are different from each other, and R_3 represents a water-insoluble polymer. A method for producing an enzyme for regenerating adenosine triphosphate. 2. The production method according to claim 1, wherein the microorganism that produces acetate kinase is Bacillus stearothermophilus. 3. The production method according to claim 1, wherein elution is performed with a buffer containing 10 mM adenosine triphosphate. 4. The production method according to claim 1, wherein elution is performed with a buffer containing 10 mM adenosine triphosphate and 100 mM potassium chloride. 5. The production method according to claim 1, wherein elution is performed with a buffer containing 10 mM adenosine triphosphate and 100 mM sodium chloride. 6. The production method according to claim 1 or 2, wherein elution is performed with a buffer containing 2mM adenosine triphosphate and 1mM fructose-1,6-diphosphate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP290080A JPS6016232B2 (en) | 1980-01-14 | 1980-01-14 | Method for producing enzyme for reproducing adenosine triphosphate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP290080A JPS6016232B2 (en) | 1980-01-14 | 1980-01-14 | Method for producing enzyme for reproducing adenosine triphosphate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5699792A JPS5699792A (en) | 1981-08-11 |
| JPS6016232B2 true JPS6016232B2 (en) | 1985-04-24 |
Family
ID=11542221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP290080A Expired JPS6016232B2 (en) | 1980-01-14 | 1980-01-14 | Method for producing enzyme for reproducing adenosine triphosphate |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6016232B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07110231B2 (en) * | 1985-11-29 | 1995-11-29 | 株式会社ヤトロン | Stabilization of acetate kinase |
| JPS62278992A (en) * | 1986-05-28 | 1987-12-03 | Unitika Ltd | Production of diadenosine-tetraphosphate or derivative thereof |
-
1980
- 1980-01-14 JP JP290080A patent/JPS6016232B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5699792A (en) | 1981-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Velours et al. | The Saccharomyces cerevisiae ATP synthase | |
| Saunders et al. | Ribonucleic acid and ribosomes of Bacillus stearothermophilus | |
| Li et al. | DNA ligase I is associated with the 21 S complex of enzymes for DNA synthesis in HeLa cells | |
| US3444042A (en) | Purified replicases and their uses | |
| CA2151257A1 (en) | Dna encoding chitin deacetylase | |
| Orth et al. | Carrier‐Bound Biologically Active Substances and Their Applications | |
| JPS6016232B2 (en) | Method for producing enzyme for reproducing adenosine triphosphate | |
| George et al. | Biospecific fractionation matrices for sequence specific endonucleases | |
| JP3486942B2 (en) | Thermostable esterase | |
| Marutzky et al. | Large scale enzymatic synthesis of nucleoside‐5′‐monophosphates using a phosphotransferase from carrots | |
| Wiederschain et al. | Specificity patterns of different types of human fucosidase: Recognition of a certain region of the pyranose ring in sugars by the enzymes | |
| JPS62126972A (en) | Novel restriction enzyme and production thereof | |
| JP2767408B2 (en) | Manufacturing method of phosphate sugar | |
| US4532214A (en) | Method for isolation of aminoacylase | |
| Brush et al. | Bacteriophage T4 deoxynucleotide kinase: gene cloning and enzyme purification | |
| JPH0244510B2 (en) | ||
| CN119506242B (en) | Terminal transferase mutant, recombinant protein, nucleic acid molecule and oligonucleotide single base extension method | |
| EP0059182B1 (en) | A process for isolating aminoacylase enzyme from a mammal kidney extract | |
| Breeze et al. | An improved method using acetyl‐coenzyme A regeneration for the enzymic inactivation of aminoglycosides prior to sterility testing | |
| CA1333698C (en) | Method of producing endo--n-acetylgalactos-aminidase from microorganisms | |
| JPS6336756B2 (en) | ||
| RU2101292C1 (en) | Method of isolation of recombinant human tumor necrosis alpha-factor | |
| Masuyoshi et al. | Purification and some properties of a chloramphenicol acetyltransferase mediated by plasmids from Vibrio anguillarum | |
| KR920006399B1 (en) | Method for Purifying Aminopeptidase from Vibrio Proteolyticus | |
| Hechtman et al. | A new from of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts |